Allergy Therapeutics to acquire Teomed AG - MarketLine Financial Deals

Allergy Therapeutics to acquire Teomed AG

Allergy Therapeutics to acquire Teomed AG - MarketLine Financial Deals
Allergy Therapeutics to acquire Teomed AG
Published Jul 01, 2010
2 pages — Published Jul 01, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Allergy Therapeutics plc has agreed to acquire the entire issued share capital of Teomed AG, a Switzerland-based pharmaceutical distribution company.

  
Source:
Document ID
MA28117_100706
Country
Country
Ticker
AGY=GB
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Allergy Therapeutics to acquire Teomed AG" Jul 01, 2010. Alacra Store. Dec 08, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Allergy-Therapeutics-to-acquire-Teomed-AG-2052-36225>
  
APA:
MarketLine Financial Deals. (2010). Allergy Therapeutics to acquire Teomed AG Jul 01, 2010. New York, NY: Alacra Store. Retrieved Dec 08, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Allergy-Therapeutics-to-acquire-Teomed-AG-2052-36225>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.